InnoVenture ue
  • PL
  • EN
InnoVenture
  • How we invest
  • Portfolio
  • News
  • Blog
  • Contact
  • Submit your project
  • PL
  • EN
  • FB
  • TW
  • IN
  • ue

News

The first round of "Development of start-ups in Eastern Poland" funding has been granted

The startups incubated by the Unicorn Hub platform take most of the available grants

Amorphis Pharma Development is working out processes for the production of stable amorphous drugs

INNOventure is investing in a project that will increase the effectiveness of medicines

Ground-penetrating radar technology is gaining support

SGPR.TECH attracts further funding

Cardiological AI at Polish universities

Cardiomatics develops cooperation with medical universities

ARA HUB accelerates its development

IDEA Global accelerator and its technology recipients appreciate ARA HUB solution

SiDLY telemedicine system at the heart of the PZU Życie and the Ministry of Health program

ER patients in Siedlce under care of SiDLY

The 4th edition of KPT Scale Up begins

Do you have a solution for the industry and you need the opportunity to implement it? Apply!

Advanced type 1 diabetes therapy, developed by Poltreg, is being commercialized

The company also develops other autoimmune diseases therapies based on its breakthrough technology

SDS Optic S.A.

The company changes its legal type

SiDLY

SiDLY gains customers, investors and recognition

We are investing in Cardiomatics

Cloud-based AI to analyze ECG data

What's new with Optimo Light (formerly: Optical Electronics)?

Project development and rebranding

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
InnoVenture

INNOventure ASI Sp. z o.o.

z siedzibą w Krakowie

NIP: 675-151-34-01

Podole 60, 30-394 Kraków

tel. +48 123 878 160

office@innoventure.vc

Company registered in Sąd Rejonowy dla Krakowa-Śródmieścia w Krakowie, XI Wydział Gospodarczy Krajowego Rejestru Sądowego (District Court for Kraków-Śródmieście in Kraków, 11th Department of Commerce of the National Court Register). Initial capital 25.759,00 zł. KRS (National Court Register) number: 0000540389.

  • BRIdge Alfa Grant Project
  • BRIdge Alfabet
  • How we invest
  • Portfolio
  • News
  • Blog